Clinicomicrobiological study of infections caused by Acinetobacter species

Sridevi Shridhar, Sevitha Bhat

Research output: Contribution to journalArticle

Abstract

Objectives: To study the rate of isolation of Acinetobacter species, its antibiogram and associated risk factors. Methods: Retrospective time bound study for 6 months. The study included 191 consecutive clinical significant isolates of Acinetobacter species isolated from various specimens. The identification and antibiotic susceptibility testing by modified Kirby Bauer and Vitek Compact system 2. Results: Maximum isolation of Acinetobacter species was from suction tip (31.94%), sputum (19.89%), urine (14.66%), blood (10.47%), and others. The species was most sensitive to colistin (97.87%) and polymyxin B (99.43%). The species was most resistant to imipenem (72.62%) and gentamicin (66.66%). The common risk factors were invasive procedure, duration of intensive care unit stay, and malignancies. Conclusion: Acinetobacter has emerged as a major nosocomial pathogen. Antibiotic resistance is on rise. Proper antibiotic stewardship is required to curtail antibiotic resistance in this region.

Original languageEnglish
Pages (from-to)223-224
Number of pages2
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume10
Issue number4
DOIs
Publication statusPublished - 01-04-2017

Fingerprint

Acinetobacter Infections
Acinetobacter
Microbial Drug Resistance
Anti-Bacterial Agents
Colistin
Polymyxin B
Imipenem
Suction
Microbial Sensitivity Tests
Gentamicins
Sputum
Intensive Care Units
Urine
Neoplasms

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

@article{090ce44e6d6c455791e214dd88fe56e2,
title = "Clinicomicrobiological study of infections caused by Acinetobacter species",
abstract = "Objectives: To study the rate of isolation of Acinetobacter species, its antibiogram and associated risk factors. Methods: Retrospective time bound study for 6 months. The study included 191 consecutive clinical significant isolates of Acinetobacter species isolated from various specimens. The identification and antibiotic susceptibility testing by modified Kirby Bauer and Vitek Compact system 2. Results: Maximum isolation of Acinetobacter species was from suction tip (31.94{\%}), sputum (19.89{\%}), urine (14.66{\%}), blood (10.47{\%}), and others. The species was most sensitive to colistin (97.87{\%}) and polymyxin B (99.43{\%}). The species was most resistant to imipenem (72.62{\%}) and gentamicin (66.66{\%}). The common risk factors were invasive procedure, duration of intensive care unit stay, and malignancies. Conclusion: Acinetobacter has emerged as a major nosocomial pathogen. Antibiotic resistance is on rise. Proper antibiotic stewardship is required to curtail antibiotic resistance in this region.",
author = "Sridevi Shridhar and Sevitha Bhat",
year = "2017",
month = "4",
day = "1",
doi = "10.22159/ajpcr.2017.v10i4.16596",
language = "English",
volume = "10",
pages = "223--224",
journal = "Asian Journal of Pharmaceutical and Clinical Research",
issn = "0974-2441",
publisher = "Innovare Academics Sciences Pvt. Ltd",
number = "4",

}

Clinicomicrobiological study of infections caused by Acinetobacter species. / Shridhar, Sridevi; Bhat, Sevitha.

In: Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, No. 4, 01.04.2017, p. 223-224.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinicomicrobiological study of infections caused by Acinetobacter species

AU - Shridhar, Sridevi

AU - Bhat, Sevitha

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Objectives: To study the rate of isolation of Acinetobacter species, its antibiogram and associated risk factors. Methods: Retrospective time bound study for 6 months. The study included 191 consecutive clinical significant isolates of Acinetobacter species isolated from various specimens. The identification and antibiotic susceptibility testing by modified Kirby Bauer and Vitek Compact system 2. Results: Maximum isolation of Acinetobacter species was from suction tip (31.94%), sputum (19.89%), urine (14.66%), blood (10.47%), and others. The species was most sensitive to colistin (97.87%) and polymyxin B (99.43%). The species was most resistant to imipenem (72.62%) and gentamicin (66.66%). The common risk factors were invasive procedure, duration of intensive care unit stay, and malignancies. Conclusion: Acinetobacter has emerged as a major nosocomial pathogen. Antibiotic resistance is on rise. Proper antibiotic stewardship is required to curtail antibiotic resistance in this region.

AB - Objectives: To study the rate of isolation of Acinetobacter species, its antibiogram and associated risk factors. Methods: Retrospective time bound study for 6 months. The study included 191 consecutive clinical significant isolates of Acinetobacter species isolated from various specimens. The identification and antibiotic susceptibility testing by modified Kirby Bauer and Vitek Compact system 2. Results: Maximum isolation of Acinetobacter species was from suction tip (31.94%), sputum (19.89%), urine (14.66%), blood (10.47%), and others. The species was most sensitive to colistin (97.87%) and polymyxin B (99.43%). The species was most resistant to imipenem (72.62%) and gentamicin (66.66%). The common risk factors were invasive procedure, duration of intensive care unit stay, and malignancies. Conclusion: Acinetobacter has emerged as a major nosocomial pathogen. Antibiotic resistance is on rise. Proper antibiotic stewardship is required to curtail antibiotic resistance in this region.

UR - http://www.scopus.com/inward/record.url?scp=85017136632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017136632&partnerID=8YFLogxK

U2 - 10.22159/ajpcr.2017.v10i4.16596

DO - 10.22159/ajpcr.2017.v10i4.16596

M3 - Article

VL - 10

SP - 223

EP - 224

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 4

ER -